Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease
- 1 December 2008
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1782 (12) , 795-799
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implicationAmerican Journal of Physiology-Renal Physiology, 2008
- The E3 Ligase MuRF1 Degrades Myosin Heavy Chain Protein in Dexamethasone-Treated Skeletal MuscleCell Metabolism, 2007
- Development of a Diagnostic Method for Detecting Increased Muscle Protein Degradation in Patients with Catabolic ConditionsJournal of the American Society of Nephrology, 2006
- The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription FactorsMolecular Cell, 2004
- Non-traditional Functions of Ubiquitin and Ubiquitin-binding ProteinsJournal of Biological Chemistry, 2003
- Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuseThe Journal of Physiology, 2002
- ENaC Degradation in A6 Cells by the Ubiquitin-Proteosome Proteolytic PathwayJournal of Biological Chemistry, 2001
- Immunologic function and survival in hemodialysis patientsKidney International, 1998
- Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle.Journal of Clinical Investigation, 1997
- Influence of ammonia and pH on protein and amino acid metabolism in LLC-PK1 cellsKidney International, 1992